Baylor College of Medicine Selects Illumina Infinium® High-Density DNA Analysis Products for Molecular Cytogenetic Services

SAN DIEGO--Illumina, Inc. (NASDAQ:ILMN) today announced that researchers at Baylor College of Medicine’s Medical Genetics Laboratories will use Illumina’s Infinium® High-Density (HD) DNA Analysis products to study genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome (PWS), Angelman syndrome (AS), and other disorders caused by uniparental disomy. Baylor College of Medicine is [...]

Bruker BioSpin Announces Two New Ultra-High Field Actively Shielded NMR Magnets to be Introduced at ENC 2009

Unique Single-Story Standard Bore 54 mm Magnet at 850 MHz and Novel Wide Bore 89 mm Magnet at 900 MHz Both Set New World Records BILLERICA, Mass.--Bruker BioSpin announced today that it will launch two new, unique and ground-breaking Ultra-High Field (UHF) NMR magnets on Sunday, March 29th, 2009 at the Experimental NMR Conference (ENC): [...]

New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations

Comprehensive, Microarray-Based Analysis Designed Specifically for Cytogeneticists SANTA CLARA, Calif.--Today, Affymetrix, Inc. (Nasdaq: AFFX) launched its next-generation series of products for cytogenetics. The entirely new solution, which includes arrays, reagents, and software, enables fast and reliable detection of known and novel chromosome aberrations. “We worked closely with the cytogenetics community to develop these products,” said [...]

Horizon Secures World-Wide Exclusive License from University of Maryland, Baltimore on new X-MAN Cell Lines

Horizon Discovery (Horizon) today announced it has secured world-wide exclusive rights to a panel of new patient-relevant human isogenic disease models developed by University of Maryland, Baltimore using its proprietary GENESIS platform. The in-licensed lines will be added to Horizon’s rapidly expanding number (150+) of X-MANTM (Mutant And Normal) cell models that allow drug discovery [...]

Pacific Biosciences Named Senior Party in Patent Interference with Life Technologies

MENLO PARK, Calif.--Pacific Biosciences, a private company developing third-generation single molecule DNA sequencing technology, announced today that it has been named the Senior Party in a patent interference declared by the United States Patent and Trademark Office with Life Technologies Corporation (LIFE). Pacific Biosciences was accorded Senior Party status based upon patent priority dates that [...]

Sirius Analytical launch new SiriusT3 instrument for fully automated ionisation, lipophilicity and solubility measurement

Sirius Analytical Ltd., (UK), a leading provider of instrumentation and analytical services to the pharmaceutical and biotech industry, have launched a new automated instrument for measurement of ionisation (pKa), lipophilicity (logP/D) and solubility (kinetic and intrinsic) using sub-milligram quantities of drug sample. The SiriusT3 system is a new state of the art hardware platform designed [...]

Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)

New 5 mL CO-RE Channel Enables High-Volume Pipetting on MICROLAB® STAR Workstations Reno, Nevada (March 24, 2009) - Hamilton Robotics announces the addition of a 5 mL channel and disposable tip to its volume range on the MICROLAB STAR liquid handling workstations. The larger 5 mL channel is the first air-displacement pipetting tool to address [...]

Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Pioneering Work in Personalized Medicine

NANTES, France & BASEL, Switzerland--Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced a collaboration with TcLand Expression, a world-leading company in the field of gene expression biomarkers for autoimmune disorders and transplantation. As part of the collaboration, the Genedata Phylosopher® and Expressionist® biomarker discovery platforms will be [...]

Xcellerex, Collaborators Receive $11 Million Phase 2 U.S. Contract to Develop Technology for Accelerated Monoclonal Antibody and Vaccine Manufacturing

MARLBORO, Mass.--Xcellerex, Inc. announced today that the company, along with three collaborators, has been awarded an $11M Phase 2 contract by the Defense Threat Reduction Agency (DTRA) - Joint Science and Technology Office, Transformational Medical Technologies Initiative (TMTI), to develop technology for accelerated monoclonal antibody and vaccine manufacturing. The Phase 2 contract follows successful completion [...]

Pilot Plant Freeze Dryer offers the ultimate in automated process control…

SP Industries Inc. has announced that it will launch the LyoStar³ pilot plant freeze dryer at the forthcoming Achema 2009 meeting in Frankfurt (Germany). The market-leading expertise of FTS Systems and VirTis in freeze drying control systems, hardware and refrigeration engineering have been brought together to create this revolutionary new system. This LyoStar³ will offer [...]

Access IBO on Knowledge Center